XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income:    
Revenue $ 0 $ 0
Expenses:    
Research and development 512,952 535,837
General and administrative 1,791,910 2,132,996
Interest 217,564 202,751
Total expenses 2,522,426 2,871,584
Other income 214,787 8,260
Net loss $ (2,307,639) $ (2,863,324)
Loss per share:    
Basic and diluted (in dollars per share) $ (0.008) $ (0.011)
Weighted average shares outstanding, basic and diluted (in shares) 277,732,088 258,337,996